Skip to content
Sumitomo Chemical logo

Sumitomo Chemical India

SUMICHEM NSE
₹340.70 −3.45 (−1.00%)
Market Cap
₹17,006 Cr
P/E
30.45
View as Markdown
MCP
Close 20 Nov 2026 ₹340.70 1Y −104.20 −23.4%
Start ₹444.90

Key Fundamentals

SmallcapFertilizers & AgrochemicalsChemicals

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
23.50%
Debt to Equity
0.01
EPS (TTM)
₹11.19
Book Value
₹73.97
Market Cap
₹17,006 Cr
P/E (TTM)
30.45
P/B
4.61
ROE
17.60%
Dividend Yield
0.38%
EBITDA
₹818 Cr
52W High
₹572.05
52W Low
₹310.85
Day Range
₹338.00 – ₹343.85
Volume
2,06,335

Peer Comparison

Commodities › Fertilizers & Agrochemicals › Pesticides & Agrochemicals

Sumitomo Chemical peer comparison
571.9525.5648,2821.391.09%5.64%10.10%52,6452,163
1,597.4027.6024,2352.120.92%11.20%15.00%6,345877
Sumitomo Chemical (this company)
340.7030.4517,0064.610.39%17.60%23.50%3,168559
3,356.2020.2315,0834.742.69%23.70%29.10%5,293746
660.709.265,9611.832.15%23.20%30.20%5,479644
909.9014.404,0562.320.21%18.50%23.80%2,013283
186.9618.463,6361.661.58%10.20%14.10%2,959197
Median 7 companies660.7020.2315,0832.121.09%17.60%23.50%5,293644

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

49 Average

Data confidence 100/100

Category scores

Quality
66
Strong
Returns, margins, earnings quality 22% weight
Valuation
38
Weak
Cheap vs sector & own history 24% weight
Growth
13
Poor
Sales & profit trajectory 9% weight
Financial Health
89
Strong
Solvency, leverage, coverage 9% weight
Momentum
11
Poor
Trend strength, vol-adjusted 12% weight
Ownership
56
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 34.5%

Weaknesses

1
  • The company has delivered a poor sales growth of 3.81% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1054
OscillatorsBullish153
Moving AveragesStrong Bearish901

Key readings

RSI (14)
40.30
Neutral
MACD (12,26,9)
−13.93
Bullish
SMA (50)
392.39
Bearish
SMA (200)
443.24
Bearish

As of

Analyst Rating

Based on 9 analysts
BUY89%

8 of 9 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
8
89%
HOLD
1
11%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+15.97%
5Y+3.81%
3Y−3.19%
1Y+3.11%
TTM−2.49%

Net profit

Net profit growth by window
10Y+23.65%
5Y+9.50%
3Y+2.58%
1Y+8.17%
TTM+3.52%

Operating cash flow

Operating cash flow growth by window
10Y+23.89%
5Y+0.88%
3Y+4.43%
1Y−3.28%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+8.61 pp
5Y+2.44 pp
3Y+1.87 pp
1Y+0.74 pp
TTM+0.26 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹799 Cr
Mar 2018₹1,911 Cr
Mar 2019₹2,223 Cr
Mar 2020₹2,423 Cr
Mar 2021₹2,643 Cr
Mar 2022₹3,060 Cr
Mar 2023₹3,511 Cr
Mar 2024₹2,833 Cr
Mar 2025₹3,090 Cr
Mar 2026₹3,186 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹62.00 Cr
Mar 2018₹145 Cr
Mar 2019₹167 Cr
Mar 2020₹206 Cr
Mar 2021₹345 Cr
Mar 2022₹434 Cr
Mar 2023₹503 Cr
Mar 2024₹370 Cr
Mar 2025₹502 Cr
Mar 2026₹543 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹686 Cr −16.2% vs FY26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 17 Nov 2026
AI opinion · based on fundamentals
Risk medium

Sumitomo Chemical India Ltd trades at ₹342.4 as of 2026-11-17 with a market cap of ₹17,091 Cr, a PE of 30.6x, and a near-zero debt-to-equity ratio of 0.02. The company has a strong long-term profit compounding record of 24% over 10 years, but recent sales and profit growth have decelerated sharply, with TTM sales declining 3% and TTM profit growing just 2%.

Bull Case 7
  • The company is virtually debt-free with a debt-to-equity ratio of just 0.02, providing significant financial flexibility and resilience through economic cycles.
  • 10-year compounded profit growth of 24% demonstrates a strong long-term earnings trajectory and sustained business model strength.
  • 10-year compounded sales growth of 16% reflects a solid track record of revenue expansion over the longer term.
  • ROCE of 20.98% indicates efficient capital deployment, suggesting the business generates healthy returns on invested capital.
  • ROE has been consistently strong, averaging 20% over 5 years and 20% over 10 years, indicating reliable shareholder value creation.
  • The company maintains a healthy dividend payout ratio of 34.5%, balancing reinvestment with shareholder returns.
  • 5-year compounded profit growth of 10% shows the business has been able to grow earnings at a reasonable pace even through recent challenging periods.
Bear Case 7
  • TTM sales growth is negative at -3%, and 3-year compounded sales growth is also -3%, indicating a sustained revenue contraction trend.
  • TTM profit growth has decelerated to just 2%, a sharp slowdown from the 10-year compounded profit growth of 24%.
  • The stock has declined 25% over the past 1 year and delivered a negative 4% CAGR over 3 years, significantly underperforming for investors.
  • PE of 30.6x is elevated relative to the TTM EPS growth of just 2%, implying the valuation is pricing in a recovery that has yet to materialize.
  • 5-year compounded sales growth of only 4% and poor past five-year sales growth of 3.81% highlight structural challenges in scaling revenues.
  • Dividend yield of 0.38% is minimal and offers limited income cushion to investors during a period of capital depreciation.
  • 5-year stock CAGR of -2% indicates that the market has not rewarded the company's operational performance over a medium-term horizon.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

22h ago

TL;DR: Sumitomo Chemical India delivered a weak Q2FY27 with declines across profit, revenue, and margins. The 297 bps EBITDA margin compression is the most notable concern, pointing to either input cost pressure or weaker pricing power. The global parent's earnings decline adds to the cautious picture. The trend is deteriorating and investors will watch for signs of margin recovery and top-line stabilization in coming quarters.

Headwinds 4
  • Q2 net profit falls 11% YoY Nov 02

    Sumitomo Chemical India reported Q2FY27 net profit of ₹157.4 crore, down 11% YoY, signaling earnings pressure.

  • EBITDA margin compresses 297 bps Nov 02

    EBITDA margin contracted by 297 basis points to 20.5% in Q2FY27, reflecting cost or pricing headwinds.

  • Revenue declines 2% YoY Nov 02

    Q2FY27 revenue came in at ₹907.3 crore, a 2% YoY decline indicating soft top-line momentum.

Quarterly Results

₹ Cr
SUMICHEM quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
903
540
664
832
971
622
665
1,048
914
552
671
1,054
891
Expenses
715
474
526
670
729
521
548
828
697
456
539
819
708
Operating Profit
188
66
139
162
242
101
117
220
217
96
133
235
183
OPM %
21%
12%
21%
19%
25%
16%
18%
21%
24%
17%
20%
22%
21%
Other Income
25
27
27
26
31
31
31
39
39
36.82
32
74
43
Interest
1
1
1
1
1
1
1
1
2
2
2
2
2
Depreciation
16
16
16
14
15
18
16
15
16
16
16
16
16
Exceptional Items
—
—
—
—
—
—
—
—
—
−15.19
—
—
—
PBT
196
76
149
173
257
113
132
242
238
100
147
291
209
Tax %
27%
27%
26%
26%
26%
25%
25%
26%
25%
25%
25%
26%
25%
Net Profit
144
55
109
128
191
84
98
180
178
75
111
217
156
EPS (₹)
2.88
1.10
2.19
2.57
3.82
1.69
1.97
3.60
3.56
1.50
2.22
4.34
3.13
YoY Sales growth
−19
−28
2
15
8
15
0
26
−6
−11
1
1
−3

Profit & Loss

₹ Cr
SUMICHEM profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
671
724
799
1,911
2,223
2,423
2,643
3,060
3,511
2,833
3,090
3,186
3,168
Expenses
614
635
698
1,691
1,932
2,088
2,155
2,458
2,843
2,358
2,467
2,520
2,522
Operating Profit
57
89
101
219
291
335
488
603
668
474
623
666
647
OPM %
8%
12%
13%
11%
13%
14%
18%
20%
19%
17%
20%
21%
20%
Other Income
8
26
10
31
0
10.84
19
36
45
96
119
146
171
Interest
1
1
1
5
5
5.51
5.56
6.17
5.39
5
6
7
6
Depreciation
6
7
7
24
28
41
47
45
52
61
63
63
64
Exceptional Items
—
—
—
—
—
−30.89
—
—
—
—
—
−15.19
—
PBT
58
107
103
221
258
267
453
586
655
503
674
727
747
Tax %
40%
40%
40%
34%
35%
23%
24%
26%
23%
27%
26%
25%
—
Net Profit
35
65
62
145
167
206
345
434
503
370
502
543
558
EPS (₹)
—
—
—
—
—
4.12
6.92
8.69
10.09
7.41
10.06
10.88
11.19
Div. Payout %
0%
0%
0%
0%
38%
18%
12%
12%
12%
80%
12%
12%
—
Sales growth
6
8
10
139
16
9
9
16
15
−19
9
3
−3

Balance Sheet

₹ Cr
SUMICHEM balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
233
233
275
275
275
499
499
499
499
499
499
499
499
Reserves
−2
63
360
665
761
710
1,029
1,425
1,881
1,941
2,397
2,885
3,193
Borrowings
0
0
0
10
20
36
33
38
34
25
45
53
46
Other Liabilities
234
280
288
695
791
848
1,097
1,047
955
822
988
997
1,198
Total Liabilities
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434
4,936
Fixed Assets
51
52
53
267
279
319
309
390
430
489
482
499
492
CWIP
0
1
7
9
8
10
14
35
71
23
28
20
21
Investments
0
0
277
2
1
87
291
357
239
425
601
1,226
1,433
Other Assets
415
523
585
1,367
1,558
1,676
2,043
2,227
2,628
2,351
2,819
2,690
2,991
Total Assets
466
576
922
1,644
1,846
2,093
2,658
3,009
3,368
3,287
3,930
4,434
4,936

Cash Flow

₹ Cr
SUMICHEM cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4
52
−21
49
75
222
424
223
389
756
458
443
Investing
−8
−5
−289
−40
−35
−118
−282
−281
−327
−426
−405
−329
Financing
0
0
276
7
−65
−61
−47
−63
−73
−331
−65
−81
Net Cash Flow
−4
47
−34
16
−26
43
95
−120
−10
−1
−11
33
Free Cash Flow
−6
44
−310
6
36
184
382
111
270
695
431
404
CFO/EBITDA
44
102
14
60
56
90
109
61
83
187
100
91

Ratios

SUMICHEM financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
83
92
101
105
110
128
117
101
98
91
90
81
Inventory Days
135
169
191
202
193
133
185
198
157
135
154
166
Days Payable
109
132
115
176
136
112
145
110
87
96
107
86
Cash Conversion Cycle
109
130
177
131
167
150
157
189
168
131
136
161
Working Capital Days
69
79
113
113
116
109
95
127
136
173
183
155
ROCE %
27%
41%
22%
29%
27%
26%
33%
34%
30%
21%
25%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sumitomo Chemical insights

61 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 75.00%
  • DIIs 9.69%
  • Public 8.99%
  • Others 3.43%
  • FIIs 2.89%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Sumitomo Chemical India

What does Sumitomo Chemical India Ltd do?
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products.
Where is Sumitomo Chemical India Ltd (SUMICHEM) listed?
Sumitomo Chemical India Ltd trades as SUMICHEM on the NSE and under code 542920 on the BSE.
Which sector does Sumitomo Chemical India Ltd belong to?
Sumitomo Chemical India Ltd is classified under the Commodities sector, in the Fertilizers & Agrochemicals industry.
What is the market capitalisation of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd has a market capitalisation of ₹17,006 Cr as of 20 Nov 2026, which places it in the Smallcap band.
What is the PE ratio of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd trades at a PE ratio of 30.45 as of 20 Nov 2026, on earnings per share of ₹11.19, against a book value of ₹73.97 per share.
What is the 52-week high and low of Sumitomo Chemical India Ltd?
Over the last 52 weeks Sumitomo Chemical India Ltd has traded between ₹310.85 and ₹572.05 as of 20 Nov 2026.
Does Sumitomo Chemical India Ltd pay dividends?
Sumitomo Chemical India Ltd has a dividend yield of 0.38%.
What is the Return on Equity (ROE) of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd reported a return on equity of 17.60%. Its debt-to-equity ratio is 0.01.

Company Information

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.

CEO Mr. Chetan Shantilal Shah
Employees 1,646
Listed 27 Jan 2020
Face Value ₹10
Shares Outstanding 49,91,45,736

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SUMICHEM.md for Sumitomo Chemical India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More